Anika Therapeutics (ANIK) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $19.98, -3.43% vs the prior close of $20.69.
- Volume 81.85K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ANIK slides 3.4% to $19.98. Closed at $19.98, -3.43% vs the prior close of $20.69. Day range $19.84–$20.73, opened at $20.73.
ANIK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ANIK slides 3.4% to $19.98
- Closed at $19.98, -3.43% vs the prior close of $20.69. Day range $19.84–$20.73, opened at $20.73.
- Volume was 81.85K shares, 0.8x its 50-day average of 105.18K.
- Price is -3.6% vs its 50-day average ($20.72) and +28.9% vs its 200-day average ($15.50).
- 52-week range $8.67–$22.88; today's close sits at 80% of that range, 12.7% below the 52-week high.
Oct 15, 2026 — ANIK rises 2.2% to $20.69
- Closed at $20.69, +2.17% vs the prior close of $20.25. Day range $20.31–$20.91, opened at $20.41.
- Volume was 84.80K shares, 0.8x its 50-day average of 105.39K.
- Price is -0.2% vs its 50-day average ($20.73) and +33.9% vs its 200-day average ($15.45).
- 52-week range $8.67–$22.88; today's close sits at 85% of that range, 9.6% below the 52-week high.
Oct 14, 2026 — ANIK dips 1.4% to $20.25
- Closed at $20.25, -1.36% vs the prior close of $20.53. Day range $20.12–$20.61, opened at $20.34.
- Volume was 93.50K shares, 0.9x its 50-day average of 108.29K.
- Price is -2.2% vs its 50-day average ($20.70) and +31.6% vs its 200-day average ($15.39).
- 52-week range $8.67–$22.88; today's close sits at 81% of that range, 11.5% below the 52-week high.
Oct 13, 2026 — ANIK ends flat (+0.3%) to $20.53, 3 up days in a row
- Closed at $20.53, +0.29% vs the prior close of $20.47. Day range $20.00–$20.77, opened at $20.47.
- Volume was 96.20K shares, 0.9x its 50-day average of 110.03K.
- Price is -0.7% vs its 50-day average ($20.68) and +33.9% vs its 200-day average ($15.34).
- 52-week range $8.67–$22.88; today's close sits at 83% of that range, 10.3% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — ANIK jumps 4.5% to $20.47
- Closed at $20.47, +4.55% vs the prior close of $19.58. Day range $19.33–$20.69, opened at $19.53.
- Volume was 152.60K shares, 1.4x its 50-day average of 110.38K.
- Price is -1.1% vs its 50-day average ($20.69) and +33.9% vs its 200-day average ($15.28).
- 52-week range $8.67–$22.88; today's close sits at 83% of that range, 10.5% below the 52-week high.
Oct 9, 2026 — ANIK rises 1.8% to $19.58
- Closed at $19.58, +1.82% vs the prior close of $19.23. Day range $19.24–$19.95, opened at $19.24.
- Volume was 88.60K shares, 0.8x its 50-day average of 110.90K.
- Price is -5.2% vs its 50-day average ($20.66) and +28.6% vs its 200-day average ($15.23).
- 52-week range $8.67–$22.88; today's close sits at 77% of that range, 14.4% below the 52-week high.
Oct 8, 2026 — ANIK dips 1.5% to $19.23
- Closed at $19.23, -1.54% vs the prior close of $19.53. Day range $18.90–$19.39, opened at $19.39.
- Volume was 126.20K shares, 1.1x its 50-day average of 110.87K.
- Price is -6.8% vs its 50-day average ($20.63) and +26.7% vs its 200-day average ($15.18).
- 52-week range $8.67–$22.88; today's close sits at 74% of that range, 16.0% below the 52-week high.
Oct 7, 2026 — ANIK rises 2.1% to $19.53
- Closed at $19.53, +2.14% vs the prior close of $19.12. Day range $18.11–$19.63, opened at $19.01.
- Volume was 182.70K shares, 1.7x its 50-day average of 108.26K.
- Price is -5.1% vs its 50-day average ($20.57) and +29.1% vs its 200-day average ($15.13).
- 52-week range $8.67–$22.88; today's close sits at 76% of that range, 14.6% below the 52-week high.
Oct 6, 2026 — ANIK slides 3.1% to $19.12
- Closed at $19.12, -3.09% vs the prior close of $19.73. Day range $19.05–$19.80, opened at $19.73.
- Volume was 64.70K shares, 0.6x its 50-day average of 107.98K — lighter than usual.
- Price is -6.7% vs its 50-day average ($20.48) and +26.8% vs its 200-day average ($15.08).
- 52-week range $8.67–$22.88; today's close sits at 74% of that range, 16.4% below the 52-week high.
Oct 5, 2026 — ANIK jumps 3.3% to $19.73
- Closed at $19.73, +3.30% vs the prior close of $19.10. Day range $19.07–$19.88, opened at $19.18.
- Volume was 122.30K shares, 1.1x its 50-day average of 106.44K.
- Price is -3.3% vs its 50-day average ($20.40) and +31.3% vs its 200-day average ($15.03).
- 52-week range $8.67–$22.88; today's close sits at 78% of that range, 13.8% below the 52-week high.
Oct 2, 2026 — ANIK dips 1.3% to $19.10, a 1-month low, 4 down days in a row
- Closed at $19.10, -1.34% vs the prior close of $19.36. Day range $19.01–$19.47, opened at $19.41.
- Volume was 92.30K shares, 0.9x its 50-day average of 105.50K.
- Price is -5.9% vs its 50-day average ($20.31) and +27.5% vs its 200-day average ($14.98).
- 52-week range $8.67–$22.88; today's close sits at 73% of that range, 16.5% below the 52-week high.
- That makes 4 straight losses.
ANIK latest news & SEC filings
Every SEC filing by or about ANIK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 7, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Fischetti Gary P bought 1,000 shares at $20.32 (≈$20.32K) on Aug 4, 2026
- Fischetti Gary P bought 1,000 shares at $20.32 (≈$20.32K) on Aug 4, 2026
- Fischetti Gary P bought 1,000 shares at $20.32 (≈$20.32K) on Aug 4, 2026
- Fischetti Gary P bought 1,000 shares at $20.32 (≈$20.32K) on Aug 4, 2026
- Fischetti Gary P bought 1,000 shares at $20.75 (≈$20.75K) on Aug 3, 2026
- Fischetti Gary P bought 1,000 shares at $20.75 (≈$20.75K) on Aug 3, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $32.61M (prior year $28.22M) (+15.6% vs Jun 30, 2025)
- Net income: $3.31M (prior year -$3.97M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.24 (prior year -$0.28) (swung to profit vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 17, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade ANIK
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Feb 26, 2026, Jan 8, 2026. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.92% (largest 4.5%).
- Liquidity: about 100.03K shares (≈$2.00M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $19.98 vs a range of $8.67–$22.88 (80% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Gary P Fischetti bought 1,000 shares on Aug 4, 2026.
- Latest filings: 10-Q Jul 29, 2026; 8-K Jul 29, 2026; 8-K Jul 14, 2026.
- Share count: 13.38M shares outstanding (Jul 24, 2026), -7.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
ANIK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 20.73 | 20.73 | 19.84 | 19.98 | 81.85K |
| Oct 15, 2026 | 20.41 | 20.91 | 20.31 | 20.69 | 84.80K |
| Oct 14, 2026 | 20.34 | 20.61 | 20.12 | 20.25 | 93.50K |
| Oct 13, 2026 | 20.47 | 20.77 | 20.00 | 20.53 | 96.20K |
| Oct 12, 2026 | 19.53 | 20.69 | 19.33 | 20.47 | 152.60K |
| Oct 9, 2026 | 19.24 | 19.95 | 19.24 | 19.58 | 88.60K |
| Oct 8, 2026 | 19.39 | 19.39 | 18.90 | 19.23 | 126.20K |
| Oct 7, 2026 | 19.01 | 19.63 | 18.11 | 19.53 | 182.70K |
| Oct 6, 2026 | 19.73 | 19.80 | 19.05 | 19.12 | 64.70K |
| Oct 5, 2026 | 19.18 | 19.88 | 19.07 | 19.73 | 122.30K |
| Oct 2, 2026 | 19.41 | 19.47 | 19.01 | 19.10 | 92.30K |
| Oct 1, 2026 | 19.55 | 19.97 | 19.09 | 19.36 | 111.90K |
| Sep 30, 2026 | 19.93 | 20.41 | 19.64 | 19.66 | 72.10K |
| Sep 29, 2026 | 20.67 | 20.67 | 19.64 | 19.95 | 151.30K |
| Sep 28, 2026 | 20.72 | 20.94 | 20.37 | 20.68 | 143.00K |
| Sep 25, 2026 | 20.23 | 20.82 | 20.13 | 20.37 | 57.70K |
| Sep 24, 2026 | 20.26 | 20.64 | 20.00 | 20.23 | 88.00K |
| Sep 23, 2026 | 20.71 | 20.71 | 20.22 | 20.38 | 62.00K |
| Sep 22, 2026 | 20.92 | 21.05 | 20.60 | 20.89 | 45.30K |
| Sep 21, 2026 | 20.81 | 21.14 | 20.45 | 20.70 | 83.50K |
About Anika Therapeutics
Anika Therapeutics (ANIK) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in BEDFORD, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 898437.
ANIK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Cheryl R Blanchard | Director | Mar 17, 2026 |
| Sheryl L Conley | Director | Jun 23, 2026 |
| Joseph H Capper | Director | Jun 23, 2026 |
| Gary P Fischetti | Director | Aug 5, 2026 |
| Stephen D. Griffin | President and CEO | Jun 5, 2026 |
| John B Iii Henneman | Director | Jun 23, 2026 |
| Stephen Richard | Director | Jun 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| David Colleran | EVP, General Counsel, Corp Sec | Mar 17, 2026 |
| Stephen D. Griffin | President and CEO | Jun 5, 2026 |
| Ian Mcleod | SVP, CAO & Treasurer | Mar 23, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Gary P Fischetti | Buy | 1,000 | $20.32 |
| Aug 4, 2026 | Gary P Fischetti | Buy | 1,000 | $20.32 |
| Aug 4, 2026 | Gary P Fischetti | Buy | 1,000 | $20.32 |
| Aug 4, 2026 | Gary P Fischetti | Buy | 1,000 | $20.32 |
| Aug 3, 2026 | Gary P Fischetti | Buy | 1,000 | $20.75 |
| Aug 3, 2026 | Gary P Fischetti | Buy | 1,000 | $20.75 |
| Aug 3, 2026 | Gary P Fischetti | Buy | 1,000 | $20.75 |
| Aug 3, 2026 | Gary P Fischetti | Buy | 1,000 | $20.75 |
| May 1, 2026 | John B Iii Henneman | Buy | 5,000 | $14.66 |
| May 1, 2026 | John B Iii Henneman | Buy | 5,000 | $14.66 |
| May 1, 2026 | John B Iii Henneman | Buy | 5,000 | $14.66 |
| May 1, 2026 | John B Iii Henneman | Buy | 5,000 | $14.66 |
| Apr 30, 2026 | Stephen D. Griffin | Buy | 12,200 | $12.29 |
| Apr 30, 2026 | Stephen D. Griffin | Buy | 12,200 | $12.29 |
| Apr 30, 2026 | Stephen D. Griffin | Buy | 12,200 | $12.29 |
ANIK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $112.82M | $-10.88M | -0.76 | $11.19M |
| Dec 31, 2024 | $119.91M | $-56.38M | -3.83 | $5.40M |
| Dec 31, 2023 | $120.79M | $-82.67M | -5.64 | $-1.79M |
| Dec 31, 2022 | $113.83M | $-14.86M | -1.02 | $4.41M |
| Dec 31, 2021 | $147.79M | $4.13M | 0.28 | $8.40M |
Latest balance sheet: total assets $183.47M, total liabilities $—, cash $38.41M (as of Jun 30, 2026).
ANIK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $16.17 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $12.39 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $12.79 |
| Jan 8, 2026 | 8-K Item 2.02 (results) | $9.55 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $9.85 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $8.10 |
| May 9, 2025 | 8-K Item 2.02 (results) | $11.64 |
| Mar 12, 2025 | 8-K Item 2.02 (results) | $17.11 |
| Oct 31, 2024 | 8-K Item 2.02 (results) | $17.11 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 13, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ANIK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.